搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Ralstonia metallidurans Protein translocase subunit SecA (secA), partial CSB-YP631805RJG
CSB-EP631805RJG
CSB-BP631805RJG
CSB-MP631805RJG
CSB-EP631805RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans Ribosomal protein L11 methyltransferase (prmA) CSB-YP631806RJG
CSB-EP631806RJG
CSB-BP631806RJG
CSB-MP631806RJG
CSB-EP631806RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans Orotidine 5'-phosphate decarboxylase (pyrF) CSB-YP631807RJG
CSB-EP631807RJG
CSB-BP631807RJG
CSB-MP631807RJG
CSB-EP631807RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans Chaperone protein DnaJ (dnaJ) CSB-YP631808RJG
CSB-EP631808RJG
CSB-BP631808RJG
CSB-MP631808RJG
CSB-EP631808RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans UPF0345 protein Rmet_2901 (Rmet_2901) CSB-YP631809RJG
CSB-EP631809RJG
CSB-BP631809RJG
CSB-MP631809RJG
CSB-EP631809RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans Methionine--tRNA ligase (metG), partial CSB-YP631810RJG
CSB-EP631810RJG
CSB-BP631810RJG
CSB-MP631810RJG
CSB-EP631810RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans tRNA (guanine-N (7)-)-methyltransferase (trmB) CSB-YP631811RJG
CSB-EP631811RJG
CSB-BP631811RJG
CSB-MP631811RJG
CSB-EP631811RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans UPF0307 protein Rmet_2571 (Rmet_2571) CSB-YP631812RJG
CSB-EP631812RJG
CSB-BP631812RJG
CSB-MP631812RJG
CSB-EP631812RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans Ferredoxin--NADP reductase 2 (Rmet_2452) CSB-YP631813RJG
CSB-EP631813RJG
CSB-BP631813RJG
CSB-MP631813RJG
CSB-EP631813RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans DNA repair protein recO (recO) CSB-YP631814RJG
CSB-EP631814RJG
CSB-BP631814RJG
CSB-MP631814RJG
CSB-EP631814RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans ATP-dependent zinc metalloprotease FtsH (ftsH), partial CSB-YP631815RJG1
CSB-EP631815RJG1
CSB-BP631815RJG1
CSB-MP631815RJG1
CSB-EP631815RJG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans UPF0133 protein Rmet_2128 (Rmet_2128) CSB-YP631816RJG
CSB-EP631816RJG
CSB-BP631816RJG
CSB-MP631816RJG
CSB-EP631816RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans Transaldolase (tal) CSB-YP631817RJG
CSB-EP631817RJG
CSB-BP631817RJG
CSB-MP631817RJG
CSB-EP631817RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans D- (-)-3-hydroxybutyrate oligomer hydrolase (Rmet_1960), partial CSB-YP631818RJG
CSB-EP631818RJG
CSB-BP631818RJG
CSB-MP631818RJG
CSB-EP631818RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans ATP-dependent Clp protease proteolytic subunit (clpP) CSB-YP631819RJG
CSB-EP631819RJG
CSB-BP631819RJG
CSB-MP631819RJG
CSB-EP631819RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans GMP synthase [glutamine-hydrolyzing] (guaA), partial CSB-YP631820RJG
CSB-EP631820RJG
CSB-BP631820RJG
CSB-MP631820RJG
CSB-EP631820RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr) CSB-YP631821RJG
CSB-EP631821RJG
CSB-BP631821RJG
CSB-MP631821RJG
CSB-EP631821RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans Succinyl-diaminopimelate desuccinylase (dapE) CSB-YP631822RJG
CSB-EP631822RJG
CSB-BP631822RJG
CSB-MP631822RJG
CSB-EP631822RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans Acetaldehyde dehydrogenase 1 (Rmet_1320) CSB-YP631823RJG
CSB-EP631823RJG
CSB-BP631823RJG
CSB-MP631823RJG
CSB-EP631823RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia metallidurans GTP cyclohydrolase folE2 1 (folE2-1) CSB-YP631824RJG
CSB-EP631824RJG
CSB-BP631824RJG
CSB-MP631824RJG
CSB-EP631824RJG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>